|
|
|
| home > epc > winter 2001 > outsourcing your clinical trial - the search for added value |
|
|
 PUBLICATIONS |
European Pharmaceutical Contractor
|
From a rational perspective, choosing a clinical research organisation (CRO) should be easy. They are numerous, the competition is high, and the nuts and bolts of all clinical trials are essentially the same. This has created a buyers' market with many clinical research organisations chasing the same work. It would therefore appear that choice of CRO can be determined by two tangible elements, namely price and capacity. To these should be added financial security, evidence of compliance to ICH and some indication that the study staff initiating your project will also be around to see it through to completion.
But is this process really rational? Surely the choice of a CRO should involve a balanced assessment of all potential factors, including those which may be considered 'soft' or difficult to quantify, but which may add significant value to your relationship?
This article will examine the real decisions that have to be made when choosing a contract partner. The examination will involve an honest appraisal of what an organisation should really hope to gain from such a partner in order to add real value to outsourcing activities as opposed to playing safe, basing a decision only on tangibles, and risking a poor return on investment.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
First-in-Human Workshop
7-8 May 2012, Berlin, Germany
More info >>
|
|
 |
News and Press Releases |
 |
Kallik’s new approach to asset management delivers long term artwork automisation
Marketing and compliance departments can now have greater control over their assets –from logos and images to labelling copy – and a roadmap to automated artwork generation, thanks to Kallik’s online Asset Repository. It is the most cost-effective way to lay the foundation for future automisation of the artwork and labelling generation. The practice of centralising the content in a web-based asset library and reusing those assets across all marketing and trade communications is saving businesses thousands, if not millions, of pounds.
More info >> |
|
|
